Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Nab-paclitaxel and Trastuzumab in HER2+ Breast Cancer
NCT01432223Phase 2Completed
- Sponsor
- Osaka Medical and Pharmaceutical University
- Start
- Sep 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in HER2-positive breast cancer, sponsored by Osaka Medical and Pharmaceutical University. Started Sep 2011; status: completed.
02
Drugs
paclitaxel
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on NCT01432223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432223.